Bone Biologics Corporatio... (BBLGW)
59.20
-8.80 (-12.94%)
At close: Jan 14, 2025, 9:00 PM
undefined% (undefined)
| Bid | 52 |
| Market Cap | 2.32M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -0.144 |
| PE Ratio (ttm) | -411.11 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 97.95 |
| Volume | 646 |
| Avg. Volume (20D) | 263 |
| Open | 59.10 |
| Previous Close | 68.00 |
| Day's Range | 59.10 - 59.20 |
| 52-Week Range | 2.87 - 70.44 |
| Beta | undefined |
About BBLGW
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. Its NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. The company is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4...
Industry Medical - Devices
Sector Healthcare
IPO Date Oct 13, 2021
Employees 2
Stock Exchange NASDAQ
Ticker Symbol BBLGW
Website http://www.bonebiologics.com